Quarterly report pursuant to Section 13 or 15(d)

NATURE OF OPERATIONS, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)

v3.21.2
NATURE OF OPERATIONS, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Product Information [Line Items]      
Cash, Uninsured Amount $ 1,603,300    
Warrant [Member]      
Product Information [Line Items]      
Antidilutive securities excluded from computation of earnings per share 1,376,466    
Employee Stock Options [Member]      
Product Information [Line Items]      
Antidilutive securities excluded from computation of earnings per share 431,266    
Series B Convertible Preferred Stock [Member]      
Product Information [Line Items]      
Antidilutive securities excluded from computation of earnings per share 243,571    
Series C Convertible Preferred Stock [Member]      
Product Information [Line Items]      
Antidilutive securities excluded from computation of earnings per share 818,182    
UNITED STATES      
Product Information [Line Items]      
Concentration percentage 84.00% 30.00%  
Revenue Benchmark [Member] | Customer 2 [Member]      
Product Information [Line Items]      
Concentration percentage 79.00% 20.00%  
Revenue Benchmark [Member] | Customer 1 [Member]      
Product Information [Line Items]      
Concentration percentage   42.00%  
Revenue Benchmark [Member] | Customer 3 [Member]      
Product Information [Line Items]      
Concentration percentage   11.00%  
Accounts Receivable [Member] | Customer 2 [Member]      
Product Information [Line Items]      
Concentration percentage 18.00%   30.00%
Accounts Receivable [Member] | Customer 1 [Member]      
Product Information [Line Items]      
Concentration percentage 65.00%   56.00%